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Abstract: Bisphenol A (BPA) is the most well-known compound from the bisphenol family. As BPA
has recently come under pressure, it is being replaced by compounds very similar in structure, but
data on the occurrence of these BPA analogues in food and human matrices are limited. The main
objective of this work was to investigate human exposure to BPA and analogues and the associated
health effects. We performed a literature review of the available research made in humans, in in vivo
and in vitro tests. The findings support the idea that exposure to BPA analogues may have an impact
on human health, especially in terms of obesity and other adverse health effects in children.
Keywords: bisphenol A analogues; food; obesogenic effect
1. Introduction
Endocrine disruptors are compounds that alter the normal functioning of the endocrine system,
and their bioaccumulation in humans may cause adverse health effects [1–3]. Bisphenol A (BPA) is
a well-known endocrine disruptor, industrially produced, largely used as a component of epoxy resins
and polycarbonate plastics [4,5]. BPA-based plastics and resins are used in the manufacturing of food
contact material such as packaging, crockery, and thermic paper. Human exposure to BPA occurs
mainly through diet (food and food contact materials) [6]. Moreover, BPA has also been found in
plastic food containers, epoxy coatings in metal cans, kitchenware toys, medical devices, and dental
composites and sealants [4,7–10].
In humans, BPA has proven to have developmental, reproductive, cardiovascular, immune, and
metabolic effects [11]. In 2017, BPA was listed in the substances of very high concern list of the European
Chemical Agency (ECHA). In view of the recent regulations that further restrict the use of BPA in food
contact materials [12–16], food packaging companies are exploring substitutes to gradually eliminate
BPA from their products [10,17,18].
Commercialization of BPA-free labeled products is increasing, while BPA analogues are being
increasingly used in the manufacturing of consumer products [10]. BPA analogues share the basic
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bisphenol structure of two benzene rings separated by a short carbon or other chemical chain [10]
(Figure 1). Bisphenol S (BPS), bisphenol F (BPF), bisphenol B (BPB), bisphenol E (BPE), and bisphenol
AF (BPAF) are chosen by the industry as a replacement for BPA in the production of polycarbonates
and epoxy resins [10,19,20] for the manufacturing of industrial and consumer products [21,22]. There
are a limited number of studies on the BPA analogues’ hormonal effects, but most show that they have
similar health concerns as BPA [23–26]. In 2002, we demonstrated the endocrine-disrupting activity
of BPA analogues in the expression of estrogen-controlled genes [27]. Furthermore, some of the BPA
substitutes seem to have more estrogenic effects than BPA [28]. Despite the regulatory actions taken in
recent years, one potential hazardous chemical is being replaced with others with similar activity and
health outcomes.
Figure 1. Bisphenols with endocrine-disrupting activity. Prepared by author based on Gallart-Ayala
et al., 2011 [29].
The health effects of BPA analogues have been reported recently in different studies [28,30].
Pelch et al., (2019) [25] concluded in a recent review that BPA analogues have health or toxicological
effects at concentrations similar to or lower than BPA. BPA analogues have proven to have bone [31],
reproductive [32], metabolic [33], oxidative stress [34], and neurological effects [35].
The considerable use of BPA analogues and their potential health risks require studies to better
understand the complex and widespread routes of human exposure. The objective of this work was to
identify data on the presence of BPA analogues in food, human biomonitoring data, and health effects
of these chemicals, especially those related to obesogenic outcomes. This was addressed by a literature
review of the available research. We hope the information in this review may be useful to move to new
regulations based on classes of chemicals rather than on an individual chemical approach.
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2. Methods
A review of the available literature was conducted in March 2019. PubMed/Medline and Scopus
databases were searched using the keywords “Bisphenol A analogues”, “Bisphenol A substitutes”,
“food”, “hormone effect”, “biological samples”, “health”, and “obesogenic effect”. Data published
between 1999 and 2019 were considered.
Figure 2 shows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
flow diagram of the literature search [36]. Study selection consisted of two screening phases. The first
selection was based on title and abstract screening, and the second selection was based on a full-text
screening. One reviewer (N.A.) conducted the two screening phases, and in case of doubt, a second
reviewer (A.R.) was consulted. The literature search yielded 572 studies. Studies were selected for
full-text screening when they met the inclusion criteria. In case of doubt, articles were also analyzed
based on their full text. Cross references were checked for additional references. Studies were excluded
after the analysis of full text if they met one of the following criteria: (a) not English language; (b) not
outcome of interest, and (c) not about the subject of the study.
Figure 2. PRISMA flow diagram of the literature search.
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3. Bisphenol A Analogues in Food
There is little information regarding the occurrence of bisphenol analogues (BPs) in foodstuffs.
Liao and Kannan [37], in a study performed in the United States, determined the presence of BPA,
BPF, and BPS (N = 267) in nine categories of foodstuffs and found that 75% of the samples contained
BPs, with total concentrations ranging between below the limit of quantification (LOQ) and 1130 ng/g
fresh weight (4.38 ng/g overall mean value). The highest overall mean concentration (sum of eight
BPs) was detected in preserved and ready-to-eat foods. The highest BPF and bisphenol P (BPP)
concentrations were 1130 ng/g and 237 ng/g, respectively, and were found in a sample of mustard
and ginger. In contrast, BPs in beverages and fruits were found in concentrations of 0.341 ng/g and
0.698 ng/g, respectively. Higher levels of individual and total BPs were detected in canned food than in
foods that came in plastic, glass, or paper containers.
Liao and Kannan [38], in a study performed in China, determined the presence of eight BPs
(N = 289) in 13 categories of foodstuffs using high-performance liquid chromatography-tandem mass
spectrometry (HPLC-MS/MS). The most frequently found BPs were BPA and BPF, which were detected
at mean value concentrations of 4.94 ng/g and 2.50 ng/g fresh weight, respectively. The highest overall
concentration (sum of eight BPs) was found in canned products (27.0 ng/g), followed by fish and
seafood (16.5 ng/g), and beverages (15.6 ng/g). In contrast, the lowest overall concentration was found
in milk and dairy products, cooking oils, and eggs (2–3 ng/g). Higher total concentration levels were
detected in canned foodstuffs (56.9 ng/g) than in foods coming in glass (0.43 ng/g), paper (11.9 ng/g),
or plastic (6.40 ng/g) containers.
Other studies have reported on the presence of BPA analogues in canned vegetables, fruits, and
soft drinks [29,39] as well as in honey [40,41], fish [41], and mustard [42]. BPF has been found in
mustard from white mustard seeds in mg kg−1 levels and is a natural reaction product formed during
its preparation. Mustard is one of the most widely used condiments worldwide and, according to some
authors, it is the main source of BPF in humans, in Europe, and probably worldwide [42]. In addition
to BPA, bisphenol A diglycidyl ether (BADGE) and bisphenol F diglycidyl ether (BFDGE) have been
detected in different milk samples from supermarkets and dairy farms [43], and BPF and BPS have
been detected in dairy products, meat and meat products, vegetables, and cereals [37].
Although BPA is the most studied BP, BADGE and BFDGE have also been detected in drinking
water as these BPs are commonly used in the epoxy coatings applied in drinking water distribution
systems. BPs from the coatings may be exposed to chemical oxidants (disinfectants) that have
the potential to form by-products with enhanced or reduced estrogenic activity than the parent
compounds [44]. Exposure to free chlorine results in rapid BP degradation (half-lives of BPs are
between <1 min to 35 min) under typical conditions [44].
There is an increasing amount of research linking long-term, low-level exposure to BPA in early
life and adverse health effects in infants and fetuses [22]. Breast milk is the main source of energy for
babies under six months and therefore it may be used as a proxy of the internal exposure levels in
mothers and fetuses. Niu et al. (2017) [22] found BPA, BPF, BPS, and BPAF in breast milk samples,
with BPA being the most abundant BP, followed by BPF. Recently, our research group has reported on
the presence of BPB, BPS, BPE, and BPP in baby food samples [10].
Table 1 summarizes the BPs found in different food samples analyzed, their concentrations, and
the analytical techniques used for detection.
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Table 1. Bisphenol analogues (BPs) found in food samples using different analytical techniques.
Reference Food Bisphenol Concentration Analytic Technique
Abou-Omar et al., 2017 [45] 27 olive oils BPA non-plastic packaging Mean = 333 µg/kgplastic packaging Mean = 150 µg/kg
High Performance Liquid Chromatography with Fluorescence
Detection (HPLC-FLD)
Alabi et al., 2014 [46]
Canned vegetables (mushroom, red pepper, olive, green beans,
asparagus), legumes (chickpeas, lentils), canned fruits (pineapple,
peach), canned fish and other seafood (mackerel, mussels, tuna,









Cacho et al., 2012 [5] Canned beverages and filling liquids of canned vegetables
BPA 0.10–0.35 µg/L Stir bar sorptive extraction combined with thermal desorption
(Gas chromatography–mass spectrometry, GC-MS)BPF 0.4 µg/L
BPZ ND
Cesen et al., 2016 [40] 36 honey samples
BPA Mean = 107 ng/g
GC-MS
BPAF Mean = 53.5 ng/g
BPE Mean = 12.8 ng/g
BPF Mean = 31.6 ng/g
BPS Mean = 302 ng/g
BPZ Mean = 28.4 ng/g
Cirillo et al., 2015 [47] Infant formulas BPA Median = 0.015 µg/g HPLC-FLD
Cunha et al., 2011 [48] 30 beverages and 7 powdered infant formulas BPA Mean = 0.115 µg/L Dispersive liquid–liquid microextraction and GC-MS
BPB Mean = 2.365 µg/L
Cunha et al., 2012 [49]
47 canned seafood samples (22 tuna, 10 sardines, 3 mackerel, 3
squid, 3 octopus, 2 mussels, 1 eel, 1 anchovy, 1 cod)
BPA 1.0–99.9 µg/kg QuEChERS (dispersive solid-phase cleanup) combined with
dispersed liquid–liquid microextraction and GC-MSBPB 21.8 µg/kg (only one sample)
Cunha and Fernandes, 2013 [50] 20 canned vegetables and 19 canned fruits BPA Mean = 265.6 µg/kg QuEChERS combined with GC-MS
BPB Mean = 3.4 µg/kg
Fasano et al., 2015 [51] 3 packed grated cheese, 2 meat, 2 fish, and 2 vegetables broths, 2white and 2 red wines, 4 pasta, 4 rice, 3 chicken and vegetables BPA 0.72–218 ng/g QuEChERS combined with GC-MS
Feshin et al., 2012 [52] Fruit and vegetable puree, canned fruit and vegetables; milk,meat puree, and canned meat BPA 2.15–42.91 ng/g GC-MS
Gallart-Ayala et al., 2011a [39] 11 canned soft drinks (soda, cola, tea, energy drink, and beer) BPA 44–607 ng/L Liquid chromatography-tandem mass spectrometry
(LC-MS/MS)BPF 218–141 ng/L
Gallart-Ayala et al., 2011b [29] 6 canned foods (vegetables and fruits) and 7 canned beverages
(soda, cola, tea, and tonic drink)
BADGE 2.3–675 µg/kg LC-MS/MS
BFDGE ND
Gallo et al., 2017 [18] 40 canned energy drink samples
BPA 0.50–3.3 ng/ml
Ultra-high performance liquid chromatography linked with
fluorescence detection (UPLC-FLD)BADGE 0.50–19.4 ng/ml
BFDGE 0.50–0.60 ng/ml




Grumetto et al., 2013 [53]
68 milk samples were packed in Tetra Pack or Tetra Brix boxes or
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Table 1. Cont.
Reference Food Bisphenol Concentration Analytic Technique
Kuo and Ding, 2004 [54] 4 soy-based infant formula powders BPA 45–113 ng/g GC-MS
Lapviboonsuk and
Leepipatpiboon, 2014 [55] 3 canned tuna BADGE ND QuEChERS and HPLC
Liao and Kannan, 2013 [37]
31 beverages, 29 dairy products, 5 fats and oils, 23 fish and
seafood, 48 cereals and cereal products, 51 meat and meat
products, 20 fruits and canned fruits, 45 vegetables and canned










Pardo et al., 2006 [56] 10 canned pig meat BADGE 83–87 ng/g
Reversed-phase HPLC coupled to atmospheric pressure
chemical ionization tandem mass spectrometryBFDGE 96–101 ng/g
Rastkari et al., 2010 [57] 12 canned tomato paste and 12 canned corn BPA 0.90–47.38 µg/kg GC-MSBPF 0.89–47.11 µg/kg
Rauter et al., 1999 [58] 142 canned oily foods BADGE 0.02–1.5 mg/kg HPLC combined with GC-MS
Sadeghi et al., 2015 [41] Canned fruits (pineapple, peach), canned vegetables (tomato),powdered milk, soft drinks, honey, and fish BPA 0.9–8.3 ng/g HPLC-FLD
Simoneau et al., 2012 [59] 449 plastic baby bottles BPA 0.5–1000 µg/kg HPLC and UPLC-MS combined with LC-MS
Viñas et al., 2010 [60]
Canned foods (peas, peas with carrots, sweet corn, artichoke,
mushroom, bean shoot, and mixed vegetables)
BPA 11.7–321 ng/mL supernatant
GC-MS in the selected ion monitoring12.9–77.7 ng/g food
BPS 8.90–175 ng/g supernatant
34.1–36.1 ng/g foods











Zhang et al., 2010 [62] Canned fish and meat
BADGE 58.76–140.72 ng/g
HPLC-FLDBFDGE 40.57–77.64 ng/g
Zoller et al., 2016 [42] 61 mustard samples BPF Mean 1.85 mg/kg
LC-MS/MS, liquid chromatography/high resolution mass
spectrometry (LC-HRMS) and gas chromatography/high
resolution mass spectrometry GC-HRMS)
Zou et al., 2012 [45]
3 canned porridge, 3 canned mushroom, 3 canned Cirrhinus
molitorella, 3 canned tuna, 3 canned anchovy, 3 canned pork, 3




ND, not detected; HPLC-FLD, high-performance liquid chromatography, fluorescence detector; GC, gas chromatography; MS, mass spectrometry; UPLC, ultra-performance liquid
chromatography; HRMS, high-resolution mass spectrometry.
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4. Bisphenol A Analogues in Biological Samples and Their Hormonal Effects
Data on BPA analogue occurrence in human samples are scarce. Human uridine 5′-diphosphate-
glucuronosyltransferases are able to rapidly metabolize BPA analogues into the corresponding BPA-
glucuronide (UGTs) [63–65]. BPA-glucuronides are rapidly excreted in urine in rats and humans [66]
and determination of urinary levels is considered a good biomarker of exposure to BPs [67].
Liao et al., (2012) [23] determined the total concentration of BPS in 315 urine samples, collected
from the U.S. and different Asian countries, and detected BPS in 81% of the samples analyzed with
variations between countries. BPS concentrations were between below the LOQ (0.02 ng/mL) and
21 ng/mL (geometric mean (GM): 0.168 ng/mL). The highest GM concentration of BPS was detected in
samples from Japan (1.18 ng/mL).
Ye et al., (2015) [68] determined the concentration of BPA, BPS, BPF, and BPAF in 616 archived
urine samples collected anonymously from volunteers during eight years. BPA was the most
frequently detected chemical (74%–99%), whereas BPAF was detected in fewer than 3% of the samples.
The detection frequencies were in the ranges of 74%–99% for BPA, 42%–88% for BPF, and 19%–74%
for BPS. GM concentrations were in the ranges of 0.36–2.07 µg/L for BPA, 0.15–0.54 µg/L for BPF, and
<0.1 to 0.25 µg/L for BPS. Although BPF concentrations were generally lower than other BPs, the
95th percentile concentration of BPF was similar or higher than that of BPA in most of the samples.
The authors conclude that the significant changes in GM concentrations of BPA and BPS are consistent
with a decline in BPA exposure and an increase in BPS exposure.
Lehmler et al., (2018) [69] investigated the association between the presence of BPA, BPF, and BPS
in urine samples from adults (N = 1808) and children (N = 868) and different demographic and lifestyle
variables; the BPA, BPS, and BPF levels were 95.7%, 89.4%, and 66.5%, respectively. In adults, the
median levels of BPA were higher (1.24 µg/L) than BPF and BPS levels (0.35 and 0.37 µg/L, respectively).
In children, the median BPA levels were also higher (1.25 µg/L) than BPF and BPS levels (0.32 and
0.29 µg/L, respectively). The study revealed associations between the different BPs and gender, race,
income, physical activity, smoking, and alcohol intake.
Exposure of pregnant women to BPs is a particular concern, as these chemicals pass from
mother to infant via breast milk, making this matrix a main target for exposure assessment of critical
subpopulations. In this framework, Deceuninck et al. (2015) [70] investigated the presence of a large
group of BPA analogues in breast milk samples (N = 30) and detected BPS in one sample at a 0.23
µg/kg concentration, whereas the rest of the BPA analogues investigated were not detected. In a study
by Niu et al. (2017) [22] also on human breast milk from Chinese mothers, BPF, BPS, and BPAF were
found, where BPA was still the most frequently compound detected, followed by BPF. This is the first
study reporting on the presence of BPF and BPAF in human breast milk.
Available studies on BPF and BPS quantification in other biological matrices are still limited.
The detection frequency of these compounds in human serum is relatively low [71]. BPS has been
found in maternal and cord blood serum [33]. More recently, Song et al. (2019) [72] found a detection
frequency of more than 65% for BPA, BPAF, and BPF in serum samples collected from residents living
near recycling facilities where e-waste was being dismantled, with GM concentrations of 3.2, 0.0074,
and 0.062 µg/mL, respectively.
The presence of BPA analogues in human biological samples suggests that it may have an effect
on the body. The estrogen activity is the most widely studied effect of BPA, and its effects on other
hormonal receptors have also been reported [65]. However, limited studies have reported that BPA
analogues have endocrine-disrupting activities similar to those of BPA [17]. The estrogenicity of BPs
was first reported in 1998 using an E-SCREEN assay in cultures of the human breast cancer cell line
MCF7 [73]. Later on, in 2002, we demonstrated the effects of these chemicals on the expression of
estrogen-controlled genes by measuring the induction of pS2 (mRNA and protein) and progesterone
receptor as well as the expression of a luciferase reporter gene transfected into MVLN cells [27].
Subsequent studies have corroborated these findings [21]. It has also been reported that the estrogenic
effect of some BPs is higher than that of BPA [74]. For example, BPS shows higher hormonal activity,
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which can likely be attributed to its strong polarity and the presence of a sulfonyl group [39,75] and its
heat stability and resistance to light [10,70]. Moreover, BPS and BPF have been shown to be involved
in breast cancer progression as much as BPA by inducing proliferation and migration of MCF-7 clonal
cells [76]. Recently, Van Leeuwen et al., (2019) [77] reported that most BPA analogues in in vitro studies
have similar or higher estrogenic activity than BPA as well as higher antiandrogenic properties. Other
BPA analogues showed both antiestrogenic and antiandrogenic activity.
BPS and BPF are the most studied bisphenol analogues. A systematic review [28] that included 32
studies (25 in vitro and 7 in vivo) revealed that the potency of BPF and BPS was in the same order of
magnitude as BPA and had similar hormonal effects. Additionally, the review showed that BPS and BPF
had hormonal effects beyond those of BPA, such as changes in organ weights and enzyme expression
levels. The authors concluded that BPS and BPF seemed to have similar potency and mechanisms
of action to those of BPA, posing similar health effects. Other authors have also reported on the
similarity between BPS and BPF and BPA in terms of their toxicological profiles, including metabolic,
carcinogenic, and reproductive effects, as well as oxidative stress and DNA damage [18,28,78–80].
Some studies in animal models have also suggested the adverse reproductive effects secondary to
exposure to BPA analogues, such as reduced sperm and oocyte quality and conversion of cholesterol
into biologically active steroid hormones (steroidogenesis). These adverse effects depend on the
duration of the exposure and the species investigated [81]. In this context, the effect of long-term BPF
exposure on the reproductive neuroendocrine system in zebrafish has been recently demonstrated [82].
Similarly, in the same animal model, BPS was shown to decrease gonad weight and alter plasma
estrogen and testosterone, as well as to reduce egg production and hatchability, with longer hatch
periods, and increase embryo malformations. Shi et al., (2018) [83] showed that prenatal exposure to
BPA analogues with physiologically relevant doses affects male reproductive functions probably due
to a spermatogenic defect in the developing testis. Ullah et al. (2019) [84] demonstrated the impact
of low-dose chronic exposure to BPB, BPF, and BPS on hypothalamo–pituitary–testicular activities
in adult rats. The effect on female reproductive functions in mice after prenatal exposure to BPA
analogues was recently demonstrated [85]. The authors concluded that prenatal exposure to bisphenols
accelerated the onset of puberty, and the mice exhibited fertility problems, abnormal estrous cyclicity,
and dysregulated expression of steroidogenic enzymes, especially with lower doses. Kolla et al.,
(2018) [86] compared the BPA and BPS exposure effect during the perinatal period on female mouse
mammary gland development. The study revealed age- and dose-specific effects of BPS that were
different from the effects of BPA. In addition, Zhou (2018) [87] evaluated low-concentration BPS toxicity
using L1 larvae of the model animal Caenorhabditis elegans. Multiple indicators at the physiological,
biochemical, and molecular levels were tested. Compared with the effects of BPA, the overall results
showed that BPS was less noxious, suggesting that individual bisphenols may have unique effects.
Other studies have also demonstrated the estrogenic, androgenic, and thyroidogenic activities of BPF
and BPS [28,71].
Eladak et al., (2015) [30] developed a fetal testis assay to demonstrate that 10 nmol/L BPS and
BPF can reduce the basal testosterone secretion by fetal human and mouse testes. Furthermore, more
recently, Desdoits-Lethimonier et al., (2017) [88] showed that, using an ex vivo culture system, BPE, BPF,
BPB, and BADGE exhibited antiandrogenic properties in adult human testes. In addition, in a study
conducted on GH3 rat cell line, BPA, BPAF, BPB, BPF, BPS, and bisphenol Z (BPZ) have been found to
alter the activity of the thyroid endocrine system, which seems to be increased by 17β-estradiol [89].
Table 2 summarizes the studies reporting on the hormonal effects of BPs.
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Table 2. Studies about hormonal effects of BPs.
Reference Species Strain Mode Dose Exposure Exposure Route Outcomes Conclusion
Desdoits-Lethimonier
et al., 2017 [88] Human
1−9 to 10−5 M for 24 or 48 h (BPA,
BPF, BFS, BFE, BPB, and BADGE)
In vitro adult testes from
prostate cancer patients
Significant dose-dependent inhibition between testosterone
levels in the culture medium and concentrations of BPA and
analogues. BPA and analogues induced inhibition of
testosterone production with variations based on duration of
exposure and BPA/analogue concentrations. Germ cells were
not affected by BPA and analogues.
Direct exposure to BPA or its analogues can
result in endocrine alteration in adult
human testes.
Eladak et al., 2015 [90] Mouse, human 10, 100, 1000, and 10,000 µmol/L(BPA, BPF, and BPS) for 48 h
In vitro human fetal testes,
in vitro mouse fetal testes
BPS or BPF reduced basal testosterone secretion. BPS or BPF
decreased Insl3 expression.
BPS and BPF result in adverse effects on
testes of mice and humans.
Kim et al., 2017 [76] Human 10
−9 to 10 −5 mol/L (BPA, BPF, and
BFS) for 24 h
In vitro human breast cancer
cells
BPA, BPS, and BPF increased proliferation of MCF-7 CV cell
line by regulating the protein expression of cell cycle-related
genes and epithelial mesenchymal transition (EMT) markers
via the ER-dependent pathway.
BPS and BPF are associated with the
increased risk of breast cancer progression as
much as BPA in the proliferation and
migration of MCF-7 CV cells.
Mokra et al., 2018 [91] Human
0.01, 0.1, and 1 µg/mL
for 4 h (BPA, BPS, BPF, and BPAF)
0.001, 0.01, and 0.1 µg/mL for 48 h
(BPA, BPS, BPF, and BPAF)
In vitro peripheral blood
mononuclear cells (PBMCs)
After 48 h, damage was present and change in PBMCs
(peripheral blood mononuclear cell) viability exposed to BPA,
BPS, BPF, and BPAF for 48 h (from 0.001 to 0.1 µg/mL for
which a decrease in cell viability did not exceed 20%).
BPA, BPS, BPF, but mostly BPAF, caused
oxidative damage to DNA in pyrimidine
bases and more strongly to purine bases in
human PBMCs. Confirmation of BPA and
BPA analogues being strongly genotoxic.
Molina-Molina et al.,
2013 [92] Human
0.01 to 10 µM (BPA, BPS, and BPF)
for 4 h
In vitro cells from
leukocyte-buffy coat
BPS, BPF, and BPA activated estrogen receptors. BPS was
more active in the estrogen receptor beta. BPF and BPA were
full androgen receptor agonist.
BPA and its analogues affect non-genomic
signaling in estrogen-responsive cells, with
potential consequences for cell function.
Naderi et al., 2014 [93] Zebrafish 0, 0.1, 1, 10, and 100 µg/L for75 days (BPS) In vivo embryos
Gonadosomatic index was reduced (≥10 µg/L) and
hepatosomatic index increased. Plasma 17β-estradiol levels
(≥1 µg/L) were increased and testosterone showed a
reduction in males (10 and 100 µg/L). An induction in plasma
vitolegenin level was observed (≥10 µg/L). Egg production
and sperm count were decreased (10 and 100 µg/L).
Postponed and decreased rates of hatching were observed.
Exposure to low doses of BPS has adverse
effects on different parts of the endocrine
system in zebrafish.
Roelofs et al., 2015 [79] Mouse
10 to 300 µM (BPA) for 48 h
0.01 to 100 µM (BPF) for 48 h
10 µM (BPS) for 48 h
10 to 100 µM (TBBPA) for 48 h
In vitro Leydig cell line M−10
BPA and BPF presented glucocorticoid receptor (GR) and
androgen receptor (AR) antagonism with IC50 values of 67
µM, 60 µM, and 22 nM for GR, and 39 µM, 20 µM, and 982
nM for AR, respectively, whereas BPS did not affect receptor
activity. Testicular steroidogenesis was altered by all BPs
tested. BPF and BPS increased the levels of progestogens that
are formed in the beginning of the steroidogenic pathway.
BPF and BPS induce Leydig cell testosterone
secretion and GR antagonism in the
nanomolar range.
Rosenmai et al., 2014
[78] Human
0.3 to 100 µM (BPA, BPB, BPE, BPF,
BPS, and BPP) for 24 h
In vitro adrenal
cortico-carcinoma cells
BPS presented less estrogenic and antiandrogenic activity
than BPA. BPS showed the largest efficacy
on17α-hydroxyprogesterone.
BPA analogues interfere with the
endocrine system.
Stroheker et al., 2003
[94] Rat
0, 25, 50, 100, and 200 mg/kg
bw/day (BPA and BPF) for 21 days In vivo system
BPA did not induce an increase in relative wet or dry uterine
weight. BPF induced a significant dose-related increase in
relative wet uterine weight at 100 mg/kg bw/day and above
and a significant increase of relative dry uterine weight at
200mg/kg bw/day.
Exposure to BPF has weak estrogenic effects
in rats. In immature rats, the effects are more
sensitive, inducing uterine growth.
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5. Obesogenic Effects of Bisphenol A Analogues
There is increasing evidence that a number of chemicals can interfere in hormonal metabolism
and regulation of adipocyte function. This may result in imbalanced hormone levels, which can lead to
obesity. These obesity-promoting compounds are known as “obesogens” [95].
It seems that genetic predisposition, unhealthy dietary habits as well as a sedentary lifestyle alone
are not responsible for the global epidemic of overweightedness and obesity [95].
At a molecular level, another mechanism by which obesogens could lead to weight gain or obesity
is through the activation of nuclear transcription factors, such as the peroxisome proliferator-activated
receptors alpha, delta, and gamma (PPARα, PPAR-δ, and PPAR-γ) and steroid hormone receptors,
that regulate adipocyte proliferation and differentiation and lipid metabolism, thereby influencing
body composition. The transcription factors bind to response elements in the DNA-regulating specific
patterns of gene expression [95]. Wassenaar et al., (2017) [96] conducted a systematic review of the
literature and found a significant positive association between early-life exposure to BPA and fat
weight and triglycerides.
BPA promotes adipogenesis, adipose tissue inflammation, and alteration of glucose and lipid
metabolism [97]. BPA has the ability to bind to human and animal PPARγ, which could trigger
obesogenic activities [98]. PPARγ is highly expressed in adipose tissue and regulates adipocyte
development and the uptake of lipids by adipocytes. Obesogens can cause obesity through direct
activation of PPARγ, but other mechanisms involve indirect activation of the receptor by increasing
the PPARγ protein and making it available to promoters of genes in the adipogenic pathway [99].
Measurements of the effects of BPA exposure on obesity should consider not only the body mass index
(BMI) but also the role of BPA in adipogenesis, lipid, and glucose dysregulation and the presence of
adipose tissue inflammation, which in turn results from the increased secretion of proinflammatory
compounds [97].
As with the hormonal effects of BPA substitutes, their obesogenic activity has not been well
studied. However, the ability of BPS to promote accumulation of lipids and differentiation of human
preadipocytes through the activation of a PPARγ pathway has been described [100]. Damage in the
transcriptome of preadipocytes during their differentiation has been described in relation to long-term
exposure to low doses of BPA or BPS and BPF [101]. As with BPA, BPS could induce differentiation
of preadipocytes. Both BPA and BPS are weak activators of PPARγ and need this receptor to induce
adipogenesis [102]. BPA and BPS can increase the differentiation of 3T3-L1 preadipocytes in mice in
a dose-dependent manner. Moreover, BPS has shown stronger adipogenic activity than BPA [102].
Ivry Del Moral et al., (2016) [103] showed that BPS can increase the harmful effects of a high-fat
diet and induce changes in the postprandial lipid metabolism, increasing fat accumulation in the
adipose tissue.
Recently, Charisiadis et al., (2018) [104] investigated the relation between obesity and the presence
of BPA and BPF in hypothalamic and white matter postmortem material from 12 pairs of obese (BMI
>30 kg/m2) and normal-weight individuals. A significant association (p < 0.05) between BPA and BPF
concentration and obesity was found, except for BPF in white matter samples.
In another study by Liu et al. (2017) [33] conducted in 1521 adults (≥20 years) who participated
in the National Health and Nutrition Examination Survey 2013–2014, significant associations were
found between BPA exposure and general and abdominal obesity, whereas no significant associations
were found for BPF or BPS, at the current exposure level. However, the authors suggested continued
biomonitoring of these BPA substitutes.
In addition, a recent study by Liu et al., (2019) [62] showed for the first time that exposure to BPF
was positively associated with a higher risk of obesity in children and adolescents. This association
was mainly found in boys, suggesting a potential gender influence.
Table 3 summarizes the studies reporting on the obesogenic effect of BPs.
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Table 3. Studies about obesogenic effects of BPs.
Reference Species Strain Model Dose Exposure Period Exposure Route Outcomes Conclusion
Ahmed and Atlas, 2016
[102] Mouse
0.01–50 µM (BPS) and 0.01–50 µM
(BPA) for 2 days In vitro 3T3-L1 cells
BPS promotes the expression of adipogenic markers and
lipid storage. Treatment of 3T3-L1 cells with BPS can
increase lipoprotein lipase, adipocyte protein 2, PPARγ
(Peroxisome proliferator-activated receptor), perilipin,
adipsin, and enhancer-binding protein alpha mRNA
expression levels. BPS and BPA can weakly activate
PPARγ using a PPARγ. BPS but not BPA was able to
competitively inhibit rosiglitazone activated PPARγ.
BPS is a more potent adipogen than BPA.
BPA and BPS can upgrade 3T3-L1 adipocyte
differentiation in a dose-dependent manner
and require PPARγ to adipogenesis.
Boucher et al., 2016 [100] Human 0.1 nM to 25 µM (BPS) for 14 days In vitro primarypreadipocytes
25 µM BPS induced lipid accumulation, increased the
mRNA and protein levels of several adipogenic markers,
including lipoprotein lipase and adipocyte protein2 (aP2).
BPS did not affect lipoprotein lipase protein levels.
BPS promotes lipid storage and
differentiation of primary human
preadipocyte.
Ivry Del Moral et al., 2016
[103] Mouse
0.2, 1.5, 50 µg/kg bw/day (BPS) for
23 weeks In vivo system
BPs induced overweightedness in male mice offspring fed
with a high-fat diet at the two highest doses of BPs.
Obesity was related to hyperinsulinemia,
hyperleptinemia, and fat mass. Plasma triglycerides were
significantly increased with BPs. Finally, BPS induced
alteration in mRNA expression of marker genes involved
in adipose tissue homeostasis.
BPS potentiates obesity in high-fat diets by
inducing lipid storage linked to faster lipid
plasma clearance.
Liu et al., 2017 [33] Human
Median urinary concentrations were:
−0.7 to 1.47 ng/L BPA
−0.1 to 1.3 ng/L BPF
−0.2 to 1.0 ng/L BPS
Human urine
Associations between BPA levels and obesity were
stronger in men (OR = 2.10; 95% CI: 1.20–3.68) than in
women and for white (OR = 2.41; 95% CI: 1.32–4.43) than
non-white participants. The associations of BPS and BPF
with general obesity did not differ by sex or ethnicity.
There was association of BPA exposure with
general obesity and abdominal obesity.
Riu et al., 2011 [98] Human, zebrafish,Xenopus
10−9 to 10−4 M (BPA, TetrabromoBPA
and tetrachloroBPA)
In vitro estrogen receptors
(ERs) and PPARs
TetrabromoBPA and tetrachloroBPA are human, zebrafish,
and Xenopus PPARγ ligands and determine the
mechanism by which these chemicals bind to an activated
PPARγ. Activation of ERα, ERβ, and PPARγ depends on
the degree of halogenation in BPA analogues. Bulkier
brominated BPA analogues have a greater capability to
activate PPARγ and a weaker estrogenic potential.
Polyhalogenated BPs could function as
obesogens acting as agonists to disrupt
physiological functions regulated by human
or animal PPARγ.




Chronic exposure of preadipocytes to BPA, or its
substitutes BPS and BPF, results in deleterious effects on
their transcriptome during differentiation of human
primary adipocytes, even at a low dose (10 nM).
Caution required over the use of BPA, BPS,
and BPF, since unsuspected cell damage
could be initiated at low doses.
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6. Conclusions
Given the similarities between BPA and BPA analogues in terms of their metabolism and actions,
including hormonal effects beyond those of BPA, it is little surprise that these substitutes also represent
a risk to wildlife and human health. Regulations on the assessment of the safety of consumer
products should be extended to cover all the compounds of the same chemical group. In addition,
as recommended by different researchers, more efforts are needed to find chemical substitutes without
hazardous health effects. The substitution trend toward BPA analogues in consumer products,
particularly in food contact materials, should be implemented with caution and include effective and
regular monitoring to assess their effects on human health.
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